HEADER HYDROLASE 21-FEB-14 4P10 TITLE PRO-CARBOXYPEPTIDASE U IN COMPLEX WITH 5-(3-AMINOPROPYL)-1-PROPYL-6,7- TITLE 2 DIHYDRO-4H-BENZIMIDAZOLE-5-CARBOXYLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBOXYPEPTIDASE B2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CARBOXYPEPTIDASE U, CPU, PLASMA CARBOXYPEPTIDASE B, PCPB, COMPND 5 THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR, TAFI; COMPND 6 EC: 3.4.17.20; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CPB2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, DRUG DISCOVERY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR K.HALLBERG,T.SJOGREN REVDAT 4 09-OCT-24 4P10 1 REMARK REVDAT 3 20-DEC-23 4P10 1 HETSYN REVDAT 2 29-JUL-20 4P10 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE REVDAT 1 13-AUG-14 4P10 0 JRNL AUTH M.BRINK,A.DAHLEN,T.OLSSON,M.POLLA,T.SVENSSON JRNL TITL DESIGN AND SYNTHESIS OF CONFORMATIONALLY RESTRICTED JRNL TITL 2 INHIBITORS OF ACTIVE THROMBIN ACTIVATABLE FIBRINOLYSIS JRNL TITL 3 INHIBITOR (TAFIA). JRNL REF BIOORG.MED.CHEM. V. 22 2261 2014 JRNL REFN ESSN 1464-3391 JRNL PMID 24588961 JRNL DOI 10.1016/J.BMC.2014.02.010 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 94.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 29202 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1547 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.06 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2129 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.52 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.2590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3254 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 158 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.66000 REMARK 3 B22 (A**2) : 3.79000 REMARK 3 B33 (A**2) : -2.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.51000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.178 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.153 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.111 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.016 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3383 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3115 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4601 ; 1.741 ; 1.943 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7151 ; 0.920 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 401 ; 7.419 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 159 ;31.920 ;23.585 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 552 ;14.168 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.583 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 498 ; 0.119 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3812 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 823 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1607 ; 2.133 ; 2.556 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1606 ; 2.131 ; 2.555 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2007 ; 2.925 ; 3.825 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2008 ; 2.924 ; 3.827 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1776 ; 2.677 ; 2.794 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1776 ; 2.677 ; 2.794 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2595 ; 3.790 ; 4.099 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4074 ; 4.927 ;21.031 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4033 ; 4.865 ;20.950 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4P10 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1000200264. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30908 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.30900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1ZG7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLISATION WAS DONE USING THE REMARK 280 HANGING DROP METHOD EQUILIBRATING OVER A WELL SOLUTION REMARK 280 CONTAINING 10% (W/V) PEG20K, 2% DIOXANE AND 0.1M BICINE PH 9.0. REMARK 280 CRYSTALS WERE THEN SOAKED IN WELL SOLUTION SUPPLEMENTED WITH 1 REMARK 280 MM COMPOUND, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.62150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 23 REMARK 465 GLN A 24 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 139 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ASP A 254 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 254 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 ASP A 370 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 224 70.75 -101.78 REMARK 500 LYS A 234 -46.64 -130.47 REMARK 500 ASN A 241 -160.97 -75.63 REMARK 500 GLU A 266 -156.37 -94.69 REMARK 500 TYR A 312 -169.96 -106.31 REMARK 500 SER A 313 -6.51 124.09 REMARK 500 THR A 361 83.51 -45.75 REMARK 500 LEU A 362 -95.74 -80.29 REMARK 500 TYR A 363 -179.12 -170.12 REMARK 500 ALA A 365 72.75 -158.46 REMARK 500 ASP A 388 -142.75 -102.81 REMARK 500 LEU A 395 61.78 -100.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 360 THR A 361 -133.28 REMARK 500 THR A 361 LEU A 362 123.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 181 ND1 REMARK 620 2 GLU A 184 OE1 125.0 REMARK 620 3 GLU A 184 OE2 89.6 55.3 REMARK 620 4 HIS A 310 ND1 101.1 100.4 154.6 REMARK 620 5 2B8 A 501 N6 114.0 109.8 94.1 102.2 REMARK 620 N 1 2 3 4 DBREF 4P10 A 23 423 UNP Q96IY4 CBPB2_HUMAN 23 423 SEQADV 4P10 THR A 347 UNP Q96IY4 ILE 347 CONFLICT SEQADV 4P10 TYR A 355 UNP Q96IY4 HIS 355 ENGINEERED MUTATION SEQADV 4P10 GLN A 357 UNP Q96IY4 HIS 357 ENGINEERED MUTATION SEQADV 4P10 LEU A 424 UNP Q96IY4 EXPRESSION TAG SEQADV 4P10 GLU A 425 UNP Q96IY4 EXPRESSION TAG SEQADV 4P10 PRO A 426 UNP Q96IY4 EXPRESSION TAG SEQRES 1 A 404 PHE GLN SER GLY GLN VAL LEU ALA ALA LEU PRO ARG THR SEQRES 2 A 404 SER ARG GLN VAL GLN VAL LEU GLN ASN LEU THR THR THR SEQRES 3 A 404 TYR GLU ILE VAL LEU TRP GLN PRO VAL THR ALA ASP LEU SEQRES 4 A 404 ILE VAL LYS LYS LYS GLN VAL HIS PHE PHE VAL ASN ALA SEQRES 5 A 404 SER ASP VAL ASP ASN VAL LYS ALA HIS LEU ASN VAL SER SEQRES 6 A 404 GLY ILE PRO CYS SER VAL LEU LEU ALA ASP VAL GLU ASP SEQRES 7 A 404 LEU ILE GLN GLN GLN ILE SER ASN ASP THR VAL SER PRO SEQRES 8 A 404 ARG ALA SER ALA SER TYR TYR GLU GLN TYR HIS SER LEU SEQRES 9 A 404 ASN GLU ILE TYR SER TRP ILE GLU PHE ILE THR GLU ARG SEQRES 10 A 404 HIS PRO ASP MET LEU THR LYS ILE HIS ILE GLY SER SER SEQRES 11 A 404 PHE GLU LYS TYR PRO LEU TYR VAL LEU LYS VAL SER GLY SEQRES 12 A 404 LYS GLU GLN ALA ALA LYS ASN ALA ILE TRP ILE ASP CYS SEQRES 13 A 404 GLY ILE HIS ALA ARG GLU TRP ILE SER PRO ALA PHE CYS SEQRES 14 A 404 LEU TRP PHE ILE GLY HIS ILE THR GLN PHE TYR GLY ILE SEQRES 15 A 404 ILE GLY GLN TYR THR ASN LEU LEU ARG LEU VAL ASP PHE SEQRES 16 A 404 TYR VAL MET PRO VAL VAL ASN VAL ASP GLY TYR ASP TYR SEQRES 17 A 404 SER TRP LYS LYS ASN ARG MET TRP ARG LYS ASN ARG SER SEQRES 18 A 404 PHE TYR ALA ASN ASN HIS CYS ILE GLY THR ASP LEU ASN SEQRES 19 A 404 ARG ASN PHE ALA SER LYS HIS TRP CYS GLU GLU GLY ALA SEQRES 20 A 404 SER SER SER SER CYS SER GLU THR TYR CYS GLY LEU TYR SEQRES 21 A 404 PRO GLU SER GLU PRO GLU VAL LYS ALA VAL ALA SER PHE SEQRES 22 A 404 LEU ARG ARG ASN ILE ASN GLN ILE LYS ALA TYR ILE SER SEQRES 23 A 404 MET HIS SER TYR SER GLN HIS ILE VAL PHE PRO TYR SER SEQRES 24 A 404 TYR THR ARG SER LYS SER LYS ASP HIS GLU GLU LEU SER SEQRES 25 A 404 LEU VAL ALA SER GLU ALA VAL ARG ALA ILE GLU LYS THR SEQRES 26 A 404 SER LYS ASN THR ARG TYR THR TYR GLY GLN GLY SER GLU SEQRES 27 A 404 THR LEU TYR LEU ALA PRO GLY GLY GLY ASP ASP TRP ILE SEQRES 28 A 404 TYR ASP LEU GLY ILE LYS TYR SER PHE THR ILE GLU LEU SEQRES 29 A 404 ARG ASP THR GLY THR TYR GLY PHE LEU LEU PRO GLU ARG SEQRES 30 A 404 TYR ILE LYS PRO THR CYS ARG GLU ALA PHE ALA ALA VAL SEQRES 31 A 404 SER LYS ILE ALA TRP HIS VAL ILE ARG ASN VAL LEU GLU SEQRES 32 A 404 PRO HET 2B8 A 501 19 HET ZN A 502 1 HET DMS A 503 4 HET NAG A 504 14 HETNAM 2B8 (5R)-5-(3-AMINOPROPYL)-1-PROPYL-4,5,6,7-TETRAHYDRO-1H- HETNAM 2 2B8 BENZIMIDAZOLE-5-CARBOXYLIC ACID HETNAM ZN ZINC ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 2B8 C14 H23 N3 O2 FORMUL 3 ZN ZN 2+ FORMUL 4 DMS C2 H6 O S FORMUL 5 NAG C8 H15 N O6 FORMUL 6 HOH *158(H2 O) HELIX 1 AA1 THR A 35 TYR A 49 1 15 HELIX 2 AA2 THR A 58 ILE A 62 5 5 HELIX 3 AA3 ASP A 76 GLY A 88 1 13 HELIX 4 AA4 ASP A 97 ASN A 108 1 12 HELIX 5 AA5 SER A 116 GLN A 122 5 7 HELIX 6 AA6 SER A 125 HIS A 140 1 16 HELIX 7 AA7 TRP A 185 TYR A 202 1 18 HELIX 8 AA8 ILE A 205 LEU A 214 1 10 HELIX 9 AA9 ASN A 224 LYS A 234 1 11 HELIX 10 AB1 ASP A 254 ASN A 258 5 5 HELIX 11 AB2 GLU A 286 ASN A 299 1 14 HELIX 12 AB3 ASP A 329 SER A 348 1 20 HELIX 13 AB4 GLY A 368 ASP A 375 1 8 HELIX 14 AB5 PRO A 397 ARG A 399 5 3 HELIX 15 AB6 TYR A 400 VAL A 423 1 24 SHEET 1 AA1 4 ILE A 51 GLN A 55 0 SHEET 2 AA1 4 VAL A 68 ASN A 73 -1 O PHE A 71 N VAL A 52 SHEET 3 AA1 4 GLY A 26 ALA A 31 -1 N ALA A 31 O VAL A 68 SHEET 4 AA1 4 CYS A 91 LEU A 95 -1 O SER A 92 N ALA A 30 SHEET 1 AA2 8 LEU A 144 SER A 151 0 SHEET 2 AA2 8 PRO A 157 VAL A 163 -1 O VAL A 160 N ILE A 147 SHEET 3 AA2 8 VAL A 215 MET A 220 -1 O PHE A 217 N VAL A 163 SHEET 4 AA2 8 ASN A 172 ASP A 177 1 N ILE A 176 O TYR A 218 SHEET 5 AA2 8 ILE A 303 SER A 311 1 O LYS A 304 N ALA A 173 SHEET 6 AA2 8 TYR A 380 LEU A 386 1 O ILE A 384 N HIS A 310 SHEET 7 AA2 8 HIS A 315 PHE A 318 -1 N HIS A 315 O GLU A 385 SHEET 8 AA2 8 THR A 354 GLN A 357 1 O THR A 354 N ILE A 316 SSBOND 1 CYS A 178 CYS A 191 1555 1555 2.02 SSBOND 2 CYS A 250 CYS A 274 1555 1555 1.98 SSBOND 3 CYS A 265 CYS A 279 1555 1555 2.09 LINK ND2 ASN A 108 C1 NAG A 504 1555 1555 1.48 LINK ND1 HIS A 181 ZN ZN A 502 1555 1555 1.75 LINK OE1 GLU A 184 ZN ZN A 502 1555 1555 2.19 LINK OE2 GLU A 184 ZN ZN A 502 1555 1555 2.46 LINK ND1 HIS A 310 ZN ZN A 502 1555 1555 2.25 LINK N6 2B8 A 501 ZN ZN A 502 1555 1555 2.02 CISPEP 1 GLN A 55 PRO A 56 0 -2.23 CISPEP 2 SER A 311 TYR A 312 0 -8.77 CISPEP 3 PRO A 319 TYR A 320 0 -0.72 CISPEP 4 ARG A 387 ASP A 388 0 -7.65 CRYST1 49.576 49.243 95.048 90.00 93.12 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020171 0.000000 0.001101 0.00000 SCALE2 0.000000 0.020307 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010537 0.00000